Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	COVID-19: Daily Top 10 Papers

Tuberculosis

Free Subscription Articles published in J Infect Dis Retrieve available abstracts of 127 articles: HTML format

Single Articles

March 2021
1. DUFFY FJ, Olson GS, Gold ES, Jahn A, et al
   A contained Mycobacterium tuberculosis mouse infection model predicts active disease and containment in humans.
   J Infect Dis. 2021 Mar 10. pii: 6167837. doi: 10.1093.
   PubMed     Abstract available
   
   
   February 2021
2. MUDDE SE, Alsoud RA, van der Meijden A, Upton AM, et al
   Predictive modeling to study the treatment-shortening potential of novel tuberculosis drug regimens, towards bundling of preclinical data.
   J Infect Dis. 2021 Feb 19. pii: 6145049. doi: 10.1093.
   PubMed     Abstract available
   
   
   
3. RAO MUVVA J, Ahmed S, Rekha RS, Kalsum S, et al
   Immunomodulatory agents combat multidrug-resistant tuberculosis by improving antimicrobial immunity.
   J Infect Dis. 2021 Feb 19. pii: 6145048. doi: 10.1093.
   PubMed     Abstract available
   
   
   
4. DUBEY N, Khan MZ, Kumar S, Sharma A, et al
   Mycobacterium tuberculosis PPiA interacts with host integrin receptor to exacerbate disease progression.
   J Infect Dis. 2021 Feb 13. pii: 6134355. doi: 10.1093.
   PubMed     Abstract available
   
   
   
5. LAI CC, Tehrani B, Yungtum G, Hsu WT, et al
   Association between the use of statins and risk of tuberculosis: a real-world analysis.
   J Infect Dis. 2021 Feb 8. pii: 6131374. doi: 10.1093.
   PubMed    
   
   
   
6. BEHR MA, Divangahi M, Schurr E
   Lessons From Bacille Calmette-Guerin for SARS-CoV-2 Vaccine Candidates.
   J Infect Dis. 2021;223:189-191.
   PubMed     Abstract available
   
   
   January 2021
7. STEIN CM, Benchek P, Bartlett J, Igo RP, et al
   Methylome-wide analysis reveals epigenetic marks associated with resistance to tuberculosis in HIV-infected individuals from East Africa.
   J Infect Dis. 2021 Jan 5. pii: 6064776. doi: 10.1093.
   PubMed     Abstract available
   
   
   November 2020
8. BARBOSA BOMFIM CC, Pinheiro Amaral E, Santiago-Carvalho I, Almeida Santos G, et al
   Granulocytic Myeloid-Derived Suppressor Cells Aggravate Tuberculosis Caused by Hypervirulent Mycobacteria.
   J Infect Dis. 2020 Nov 18. pii: 5989003. doi: 10.1093.
   PubMed     Abstract available
   
   
   October 2020
9. HJORT K, Juren P, Toro JC, Hoffner S, et al
   Dynamics of extensive drug resistance evolution of Mycobacterium tuberculosis in a single patient during 9 years of disease and treatment.
   J Infect Dis. 2020 Oct 12. pii: 5921146. doi: 10.1093.
   PubMed     Abstract available
   
   
   
10. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    Corrigendum to: System-Wide Analysis Unravels the Differential Regulation and In Vivo Essentiality of Virulence-Associated Proteins B and C Toxin-Antitoxin Systems of Mycobacterium tuberculosis.
    J Infect Dis. 2020 Oct 7. pii: 5918919. doi: 10.1093.
    PubMed    
    
    
    September 2020
11. LOONEY MM, Lu Y, Karakousis PC, Halushka MK, et al
    Mycobacterium tuberculosis infection drives mitochondria-biased dysregulation of host tRNA-derived fragments.
    J Infect Dis. 2020 Sep 22. pii: 5909842. doi: 10.1093.
    PubMed     Abstract available
    
    
    
12. ZHANG S, Li G, Bi J, Guo Q, et al
    Functional nucleotide polymorphisms up-regulating transforming growth factor beta1 expression are associated with increased tuberculosis susceptibility.
    J Infect Dis. 2020 Sep 16. pii: 5906652. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2020
13. EISENHUT M
    The influence of cigarette smoke on results of hematological and immunological investigations in patients exposed to Mycobacterium tuberculosis.
    J Infect Dis. 2020 Jul 29. pii: 5877958. doi: 10.1093.
    PubMed    
    
    
    
14. CAMPBELL N, Verrall AJ, Donkor S, Sutherland JS, et al
    BCG protection against Mycobacterium tuberculosis infection by level of exposure in The Gambia.
    J Infect Dis. 2020 Jul 8. pii: 5868549. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2020
15. DUTTA NK, Karakousis PC
    Reply to Hu et al: Could there be detrimental effects of statin adjunctive TB therapy on immune responses?
    J Infect Dis. 2020;222:336-337.
    PubMed    
    
    
    May 2020
16. OSAWA T, Watanabe M, Morimoto K, Okumura M, et al
    Serum procalcitonin levels predict mortality risk in patients with pulmonary tuberculosis: a single-center prospective observational study.
    J Infect Dis. 2020 May 23. pii: 5843442. doi: 10.1093.
    PubMed     Abstract available
    
    
    
17. HE X, Eddy JJ, Jacobson KR, Henderson AJ, et al
    Enhanced HIV-1 Replication in CD4+ T Cells Derived from Individuals with Latent Mycobacterium tuberculosis Infection.
    J Infect Dis. 2020 May 16. pii: 5838261. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2020
18. KUMAR NP, Kathamuthu GR, Moideen K, Banurekha VV, et al
    Strongyloides stercoralis coinfection is associated with greater disease severity, higher bacterial burden and elevated plasma matrix metalloproteinases in pulmonary tuberculosis.
    J Infect Dis. 2020 Apr 20. pii: 5822617. doi: 10.1093.
    PubMed     Abstract available
    
    
    
19. SULIMAN S, Gela A, Mendelsohn SC, Iwany SK, et al
    Peripheral blood mucosal-associated invariant T (MAIT) cells in tuberculosis patients and healthy Mycobacterium tuberculosis-exposed controls.
    J Infect Dis. 2020 Apr 8. pii: 5817894. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2020
20. KAUSHAL D
    The Comeback Kid: BCG.
    J Infect Dis. 2020;221:1031-1032.
    PubMed    
    
    
    February 2020
21. LU LL, Das J, Grace PS, Fortune SM, et al
    Antibody Fc Glycosylation Discriminates Between Latent and Active Tuberculosis.
    J Infect Dis. 2020 Feb 15. pii: 5736363. doi: 10.1093.
    PubMed     Abstract available
    
    
    
22. EISINGER RW, Embry AC, Read SW, Fauci AS, et al
    2019: A Banner Year for Tuberculosis Research.
    J Infect Dis. 2020 Feb 11. pii: 5719366. doi: 10.1093.
    PubMed     Abstract available
    
    
    January 2020
23. CLICK ES, Kurbatova E, Alexander H, Dalton TL, et al
    Isoniazid- and Rifampin-Resistance Mutations Associated with Resistance to Second-line Drugs and with Sputum Culture Conversion.
    J Infect Dis. 2020 Jan 31. pii: 5718252. doi: 10.1093.
    PubMed     Abstract available
    
    
    
24. BIGELOW KM, Deitchman AN, Li SY, Barnes-Boyle K, et al
    Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis.
    J Infect Dis. 2020 Jan 29. pii: 5716916. doi: 10.1093.
    PubMed     Abstract available
    
    
    
25. SONG Y, Hussain T, Wang J, Liao Y, et al
    Mitochondrial Transcription Factor A Regulates Mycobacterium bovis-Induced IFN-beta Production by Modulating Mitochondrial DNA Replication in Macrophages.
    J Infect Dis. 2020;221:438-448.
    PubMed     Abstract available
    
    
    December 2019
26. HU Z, Lowrie DB, Fan XY
    Statins as adjunctive therapy against tuberculosisthe balance between statin-induced anti-TB effect and trained immunity suppression.
    J Infect Dis. 2019 Dec 24. pii: 5686380. doi: 10.1093.
    PubMed    
    
    
    
27. ALBERTO CHORENO-PARRA J, Bobba S, Rangel-Moreno J, Ahmed M, et al
    Mycobacterium tuberculosis HN878 infection induces human-like B cell follicles in mice.
    J Infect Dis. 2019 Dec 13. pii: 5674951. doi: 10.1093.
    PubMed     Abstract available
    
    
    
28. TORNHEIM JA, Madugundu AK, Paradkar M, Fukutani KF, et al
    Transcriptomic Profiles of Confirmed Pediatric Tuberculosis Patients and Household Contacts Identifies Active Tuberculosis, Infection, and Treatment Response among Indian Children.
    J Infect Dis. 2019 Dec 4. pii: 5651247. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2019
29. PEETLUK LS, Rebeiro PF, Cordeiro-Santos M, Kritski A, et al
    Lack of weight gain during the first two months of treatment and HIV independently predict unsuccessful treatment outcomes in tuberculosis.
    J Infect Dis. 2019 Nov 14. pii: 5625394. doi: 10.1093.
    PubMed     Abstract available
    
    
    
30. STOCKDALE L, Nash S, Farmer R, Raynes J, et al
    Cytomegalovirus antibody responses associated with increased risk of TB disease in Ugandan adults.
    J Infect Dis. 2019 Nov 5. pii: 5613526. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2019
31. SIMMONS JD, Peterson GJ, Campo M, Lohmiller J, et al
    Nicotinamide limits replication of Mycobacterium tuberculosis and BCG within macrophages.
    J Infect Dis. 2019 Oct 31. pii: 5610259. doi: 10.1093.
    PubMed     Abstract available
    
    
    
32. STEIN CM, Mayanja-Kizza H, Hawn TR, Boom WH, et al
    Importance of study design and phenotype definition in ongoing studies of resistance to latent M. tuberculosis infection.
    J Infect Dis. 2019 Oct 30. pii: 5609437. doi: 10.1093.
    PubMed    
    
    
    
33. SAKAMURI RM, Singh KK, Ryndak MB, Laal S, et al
    Evolution of antibodies to epitopes of PE_PGRS51 in the spectrum of active pulmonary tuberculosis.
    J Infect Dis. 2019 Oct 23. pii: 5602685. doi: 10.1093.
    PubMed     Abstract available
    
    
    
34. DUTTA NK, Bruiners N, Zimmerman MD, Tan S, et al
    Adjunctive host-directed therapy with statins improves tuberculosis-related outcomes in mice.
    J Infect Dis. 2019 Oct 12. pii: 5586531. doi: 10.1093.
    PubMed     Abstract available
    
    
    
35. NATHAVITHARANA RR, Yoon C, Macpherson P, Dowdy DW, et al
    Guidance for Studies Evaluating the Accuracy of Tuberculosis Triage Tests.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
36. GEORGHIOU SB, Schumacher SG, Rodwell TC, Colman RE, et al
    Guidance for Studies Evaluating the Accuracy of Rapid Tuberculosis Drug-Susceptibility Tests.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
37. DRAIN PK, Gardiner J, Hannah H, Broger T, et al
    Guidance for Studies Evaluating the Accuracy of Biomarker-Based Nonsputum Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
38. SCHUMACHER SG, Wells WA, Nicol MP, Steingart KR, et al
    Guidance for Studies Evaluating the Accuracy of Sputum-Based Tests to Diagnose Tuberculosis.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    
39. DENKINGER CM, Schumacher SG, Gilpin C, Korobitsyn A, et al
    Guidance for the Evaluation of Tuberculosis Diagnostics That Meet the World Health Organization (WHO) Target Product Profiles: An Introduction to WHO Process and Study Design Principles.
    J Infect Dis. 2019;220.
    PubMed     Abstract available
    
    
    August 2019
40. KATELARIS AL, Jackson C, Southern J, Gupta RK, et al
    Effectiveness of BCG vaccination against Mycobacterium tuberculosis infection in adults: a cross-sectional analysis of a UK-based cohort.
    J Infect Dis. 2019 Aug 29. pii: 5556484. doi: 10.1093.
    PubMed     Abstract available
    
    
    
41. RIOU C, Jhilmeet N, Rangaka MX, Wilkinson RJ, et al
    Tuberculosis antigen-specific T cell responses during the first 6 months of antiretroviral treatment.
    J Infect Dis. 2019 Aug 17. pii: 5550849. doi: 10.1093.
    PubMed     Abstract available
    
    
    
42. WU Q, Hossfeld A, Gerberick A, Saljoughian N, et al
    Mycobacterium tuberculosis enhances macrophage P-glycoprotein (MDR1) expression and activity to promote intracellular survival during anti-TB drug treatment.
    J Infect Dis. 2019 Aug 14. pii: 5549997. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2019
43. VERRALL AJ, Alisjahbana B, Apriani L, Novianty N, et al
    Early Clearance of Mycobacterium tuberculosis: The INFECT Case Contact Cohort Study in Indonesia.
    J Infect Dis. 2019 Jul 12. pii: 5531576. doi: 10.1093.
    PubMed     Abstract available
    
    
    
44. LALVANI A, Seshadri C
    Understanding How BCG Vaccine Protects Against Mycobacterium tuberculosis Infection: Lessons From Household Contact Studies.
    J Infect Dis. 2019 Jul 12. pii: 5531579. doi: 10.1093.
    PubMed    
    
    
    
45. HORTLE E, Johnson KE, Johansen MD, Nguyen T, et al
    Thrombocyte Inhibition Restores Protective Immunity to Mycobacterial Infection in Zebrafish.
    J Infect Dis. 2019;220:524-534.
    PubMed     Abstract available
    
    
    June 2019
46. AFKHAMI S, Lai R, D'Agostino MR, Vaseghi-Shanjani M, et al
    Single-dose mucosal immunotherapy with chimpanzee adenovirus-based vaccine accelerates TB disease control and limits its rebound following antibiotic cessation.
    J Infect Dis. 2019 Jun 13. pii: 5519039. doi: 10.1093.
    PubMed     Abstract available
    
    
    
47. HU Z, Lu SH, Lowrie DB, Fan XY, et al
    Reply to Tonby et al.
    J Infect Dis. 2019;220:176-178.
    PubMed    
    
    
    
48. SHAH JA, Lindestam Arlehamn CS, Horne DJ, Sette A, et al
    Non-tuberculous Mycobacteria and Heterologous Immunity to Tuberculosis.
    J Infect Dis. 2019 Jun 4. pii: 5511511. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2019
49. KROEZE S, Wit FW, Rossouw TM, Steel HC, et al
    Plasma biomarkers of HIV-related systemic inflammation and immune activation in sub-Saharan Africa before and during suppressive antiretroviral therapy.
    J Infect Dis. 2019 May 14. pii: 5489039. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2019
50. BLUMENTHAL MJ, Schutz C, Barr D, Locketz M, et al
    The contribution of KSHV to mortality in hospitalized HIV-infected patients being investigated for tuberculosis in South Africa.
    J Infect Dis. 2019 Apr 20. pii: 5475547. doi: 10.1093.
    PubMed     Abstract available
    
    
    
51. YANG D, He X, Li S, Liu J, et al
    Rv1075c of Mycobacterium tuberculosis is a GDSL-Like Esterase and is Important for Intracellular Survival.
    J Infect Dis. 2019 Apr 18. pii: 5475176. doi: 10.1093.
    PubMed     Abstract available
    
    
    
52. VERRALL AJ, Schneider M, Alisjahbana B, Apriani L, et al
    Early clearance of Mycobacterium tuberculosis is associated with increased innate immune responses.
    J Infect Dis. 2019 Apr 8. pii: 5431213. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2019
53. ELKINGTON P, Lerm M, Kapoor N, Mahon R, et al
    In Vitro Granuloma Models of Tuberculosis: Potential and Challenges.
    J Infect Dis. 2019 Mar 31. pii: 5423999. doi: 10.1093.
    PubMed     Abstract available
    
    
    
54. MOLIVA JI, Duncan MA, Olmo-Fontanez A, Akhter A, et al
    The lung mucosa environment in the elderly increases host susceptibility to Mycobacterium tuberculosis infection.
    J Infect Dis. 2019 Mar 29. pii: 5422213. doi: 10.1093.
    PubMed     Abstract available
    
    
    
55. TONBY K, Mortensen R, Ruhwald M, Dyrhol-Riise AM, et al
    KLRG1-Expressing CD4 T Cells Are Reduced in Tuberculosis Patients Compared to Healthy Mycobacterium tuberculosis-Infected Subjects, but Increase With Treatment.
    J Infect Dis. 2019 Mar 19. pii: 5387565. doi: 10.1093.
    PubMed    
    
    
    
56. CANCINO-MUNOZ I, Moreno-Molina M, Furio V, Goig GA, et al
    Cryptic resistance mutations associated to misdiagnoses of Multidrug-resistant tuberculosis.
    J Infect Dis. 2019 Mar 15. pii: 5381710. doi: 10.1093.
    PubMed     Abstract available
    
    
    
57. DEY RJ, Dey B, Singh AK, Praharaj M, et al
    BCG overexpressing an endogenous STING agonist provides enhanced protection against pulmonary tuberculosis.
    J Infect Dis. 2019 Mar 15. pii: 5381716. doi: 10.1093.
    PubMed     Abstract available
    
    
    
58. TER BEEK L, Alffenaar JC, Bolhuis MS, van der Werf TS, et al
    Tuberculosis-related Malnutrition: Public Health Implications.
    J Infect Dis. 2019 Mar 5. pii: 5369706. doi: 10.1093.
    PubMed    
    
    
    February 2019
59. LACHMANDAS E, Eckold C, Bohme J, Koeken VACM, et al
    Metformin alters human host responses to Mycobacterium tuberculosis in healthy subjects.
    J Infect Dis. 2019 Feb 12. pii: 5316196. doi: 10.1093.
    PubMed     Abstract available
    
    
    
60. ADAMS KN, Verma AK, Gopalaswamy R, Adikesavalu H, et al
    Diverse Clinical Isolates of Mycobacterium tuberculosis Develop Macrophage-Induced Rifampin Tolerance.
    J Infect Dis. 2019 Feb 7. pii: 5308873. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2018
61. DESHPANDE D, Pasipanodya JG, Srivastava S, Martin KR, et al
    Minocycline Immunomodulates via Sonic Hedgehog Signaling and Apoptosis and Has Direct Potency Against Drug-Resistant Tuberculosis.
    J Infect Dis. 2018 Dec 28. pii: 5263980. doi: 10.1093.
    PubMed     Abstract available
    
    
    
62. FRANK DJ, Horne DJ, Dutta NK, Shaku MT, et al
    Remembering the Host in Tuberculosis Drug Development.
    J Infect Dis. 2018 Dec 21. pii: 5257354. doi: 10.1093.
    PubMed     Abstract available
    
    
    
63. KOEKEN VACM, Lachmandas E, Riza A, Matzaraki V, et al
    The role of glutamine metabolism for host defense against Mycobacterium tuberculosis infection.
    J Infect Dis. 2018 Dec 12. pii: 5239862. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2018
64. SINHA P, Davis J, Saag L, Wanke C, et al
    Undernutrition and Tuberculosis: Public Health Implications.
    J Infect Dis. 2018 Nov 22. pii: 5197537. doi: 10.1093.
    PubMed     Abstract available
    
    
    
65. TOMASICCHIO M, Davids M, Pooran A, Theron G, et al
    The injectable contraceptive medroxyprogesterone acetate attenuates Mycobacterium tuberculosis-specific host immunity through the glucocorticoid receptor.
    J Infect Dis. 2018 Nov 19. pii: 5191220. doi: 10.1093.
    PubMed     Abstract available
    
    
    October 2018
66. MAYITO J, Andia I, Belay M, Jolliffe DA, et al
    Anatomic and Cellular Niches for Mycobacterium tuberculosis in Latent Tuberculosis Infection.
    J Infect Dis. 2018 Oct 30. pii: 5146773. doi: 10.1093.
    PubMed     Abstract available
    
    
    
67. AMARAL EP, Machado de Salles E, Barbosa Bomfim CC, Salgado RM, et al
    Inhibiting Adenosine Receptor Signaling Promotes Accumulation of Effector CD4+ T Cells in the Lung Parenchyma During Severe Tuberculosis.
    J Infect Dis. 2018 Oct 11. pii: 5126506. doi: 10.1093.
    PubMed     Abstract available
    
    
    
68. THUONG NTT, Vinh DN, Hai HT, Thu DDA, et al
    Pre-treatment cerebrospinal fluid bacterial load correlates with inflammatory response and predicts neurological events during tuberculous meningitis treatment.
    J Infect Dis. 2018 Oct 9. pii: 5123684. doi: 10.1093.
    PubMed     Abstract available
    
    
    September 2018
69. ARUMUGAM P, Shankaran D, Bothra A, Gandotra S, et al
    The MmpS6-MmpL6 operon is an oxidative stress response system providing selective advantage to Mycobacterium tuberculosis in stress.
    J Infect Dis. 2018 Sep 7. pii: 5092676. doi: 10.1093.
    PubMed     Abstract available
    
    
    August 2018
70. SHIN SS, Modongo C, Baik Y, Allender C, et al
    Mixed infections are associated with poor treatment outcomes among newly diagnosed tuberculosis patients independent of pre-treatment heteroresistance.
    J Infect Dis. 2018 Aug 4. pii: 5066433. doi: 10.1093.
    PubMed     Abstract available
    
    
    July 2018
71. GEBREMICAEL G, Kassa D, Quinten E, Alemayehu Y, et al
    Host gene expression kinetics during treatment of tuberculosis in HIV-coinfected individuals is independent of HAART therapy.
    J Infect Dis. 2018 Jul 2. pii: 5047436. doi: 10.1093.
    PubMed     Abstract available
    
    
    June 2018
72. NELSON KN, Shah NS, Mathema B, Ismail N, et al
    Spatial Patterns of Extensively drug-resistant Tuberculosis (XDR-tuberculosis) transmission in KwaZulu-Natal, South Africa.
    J Infect Dis. 2018 Jun 28. pii: 5046349. doi: 10.1093.
    PubMed     Abstract available
    
    
    
73. ORDONEZ AA, Pokkali S, Sanchez-Bautista J, Klunk MH, et al
    Matrix Metalloproteinase Inhibition in a Murine Model of Cavitary Tuberculosis Paradoxically Worsens Pathology.
    J Infect Dis. 2018 Jun 16. pii: 5039594. doi: 10.1093.
    PubMed     Abstract available
    
    
    May 2018
74. MAHLA RS
    KLRG1 Signaling is Contextual to Tuberculosis Immunity.
    J Infect Dis. 2018 May 28. pii: 5017236. doi: 10.1093.
    PubMed    
    
    
    
75. REICHLER MR, Khan A, Sterling TR, Zhao H, et al
    Risk and Timing of Tuberculosis Among Close Contacts of Persons with Infectious Tuberculosis.
    J Infect Dis. 2018 May 15. pii: 4996045. doi: 10.1093.
    PubMed     Abstract available
    
    
    
76. GUTHRIE JL, Delli Pizzi A, Roth D, Kong C, et al
    Genotyping and Whole Genome Sequencing to Identify Tuberculosis Transmission to Pediatric Patients in British Columbia, Canada, 2005-2014.
    J Infect Dis. 2018 May 11. pii: 4995040. doi: 10.1093.
    PubMed     Abstract available
    
    
    April 2018
77. MILLER AC, Livchits V, Ahmad Khan F, Atwood S, et al
    Turning off the tap: Using the FAST approach to stop the spread of drug-resistant tuberculosis in Russian Federation.
    J Infect Dis. 2018 Apr 5. pii: 4961495. doi: 10.1093.
    PubMed     Abstract available
    
    
    
78. LACHMANDAS E, Rios-Miguel AB, Koeken VACM, van der Pasch E, et al
    Tissue metabolic changes drive cytokine responses to Mycobacterium tuberculosis.
    J Infect Dis. 2018 Apr 3. pii: 4959339. doi: 10.1093.
    PubMed     Abstract available
    
    
    March 2018
79. URBANOWSKI ME, Ihms EA, Bigelow K, Kubler A, et al
    Repetitive Aerosol Exposure Promotes Cavitary Tuberculosis and Enables Screening for Targeted Inhibitors of Extensive Lung Destruction.
    J Infect Dis. 2018 Mar 15. pii: 4936447. doi: 10.1093.
    PubMed     Abstract available
    
    
    
80. MURRAY LW, Satti I, Meyerowitz J, Jones M, et al
    Human Immunodeficiency Virus Infection Impairs Th1 and Th17 Mycobacterium tuberculosis-Specific T-Cell Responses.
    J Infect Dis. 2018 Mar 13. pii: 4932783. doi: 10.1093.
    PubMed     Abstract available
    
    
    February 2018
81. AGARWAL S, Tiwari P, Deep A, Kidwai S, et al
    System wide analysis unravels differential regulation and in vivo essentiality of VapBC TA systems from Mycobacterium tuberculosis.
    J Infect Dis. 2018 Feb 24. pii: 4909395. doi: 10.1093.
    PubMed     Abstract available
    
    
    
82. REECE ST, Vogelzang A, Tornack J, Bauer W, et al
    Mycobacterium tuberculosis-Infected Hematopoietic Stem and Progenitor Cells Unable to Express Inducible Nitric Oxide Synthase Propagate Tuberculosis in Mice.
    J Infect Dis. 2018 Feb 17. pii: 4869967. doi: 10.1093.
    PubMed     Abstract available
    
    
    
83. CHUNG YT, Pasquinelli V, Jurado JO, Wang X, et al
    Elevated cyclic AMP Inhibits Mycobacterium tuberculosis-stimulated T cell IFN-gamma Secretion through type I Protein Kinase A.
    J Infect Dis. 2018 Feb 8. pii: 4845549. doi: 10.1093.
    PubMed     Abstract available
    
    
    
84. KURODA MJ, Sugimoto C, Cai Y, Merino KM, et al
    High Turnover of Tissue Macrophages Contributes to Tuberculosis Reactivation in Simian Immunodeficiency Virus-Infected Rhesus Macaques.
    J Infect Dis. 2018 Feb 8. pii: 4843840. doi: 10.1093.
    PubMed     Abstract available
    
    
    
85. KHAN N, Divangahi M
    Mycobacterium tuberculosis and HIV Coinfection Brings Fire and Fury to Macrophages.
    J Infect Dis. 2018 Feb 8. pii: 4843841. doi: 10.1093.
    PubMed    
    
    
    January 2018
86. PAIDIPALLY P, Tripathi D, Van A, Radhakrishnan RK, et al
    IL-21 regulates NK cell responses during Mycobacterium tuberculosis infection.
    J Infect Dis. 2018 Jan 30. pii: 4829454. doi: 10.1093.
    PubMed     Abstract available
    
    
    
87. HU Z, Zhao HM, Li CL, Liu XH, et al
    The role of KLRG1 in human CD4+ T cell immunity against tuberculosis.
    J Infect Dis. 2018 Jan 24. pii: 4823593. doi: 10.1093.
    PubMed     Abstract available
    
    
    
88. THOMPSON EG, Shankar S, Gideon HP, Braun J, et al
    Blood RNA signatures prospectively discriminate controllers from progressors early after low-dose M. tuberculosis infection of cynomolgus macaques.
    J Infect Dis. 2018 Jan 8. pii: 4792952. doi: 10.1093.
    PubMed     Abstract available
    
    
    December 2017
89. ZHENG R, Liu H, Zhou Y, Yan D, et al
    Notch4 Negatively Regulates the Inflammatory Response to Mycobacterium tuberculosis Infection by Inhibiting TAK1 Activation.
    J Infect Dis. 2017 Dec 8. pii: 4712145. doi: 10.1093.
    PubMed     Abstract available
    
    
    November 2017
90. GARFIN C, Mantala M, Yadav R, Hanson CL, et al
    Using Patient Pathway Analysis to Design Patient-centered Referral Networks for Diagnosis and Treatment of Tuberculosis: The Case of the Philippines.
    J Infect Dis. 2017;216.
    PubMed     Abstract available
    
    
    
91. HANSON C, Osberg M, Brown J, Durham G, et al
    Finding the Missing Patients With Tuberculosis: Lessons Learned From Patient-Pathway Analyses in 5 Countries.
    J Infect Dis. 2017;216.
    PubMed     Abstract available
    
    
    
92. HANSON CL, Osberg M, Brown J, Durham G, et al
    Conducting Patient-Pathway Analysis to Inform Programming of Tuberculosis Services: Methods.
    J Infect Dis. 2017;216.
    PubMed     Abstract available
    
    
    
93. MASINI E, Hanson C, Ogoro J, Brown J, et al
    Using Patient-Pathway Analysis to Inform a Differentiated Program Response to Tuberculosis: The Case of Kenya.
    J Infect Dis. 2017;216.
    PubMed     Abstract available
    
    
    
94. FATIMA R, Haq MU, Yaqoob A, Mahmood N, et al
    Delivering Patient-Centered Care in a Fragile State: Using Patient-Pathway Analysis to Understand Tuberculosis-Related Care Seeking in Pakistan.
    J Infect Dis. 2017;216.
    PubMed     Abstract available
    
    
    
95. SURYA A, Setyaningsih B, Suryani Nasution H, Gita Parwati C, et al
    Quality Tuberculosis Care in Indonesia: Using Patient Pathway Analysis to Optimize Public-Private Collaboration.
    J Infect Dis. 2017;216.
    PubMed     Abstract available
    
    
    
96. FEKADU L, Hanson C, Osberg M, Makayova J, et al
    Increasing Access to Tuberculosis Services in Ethiopia: Findings From a Patient-Pathway Analysis.
    J Infect Dis. 2017;216.
    PubMed     Abstract available
    
    
    
97. SISMANIDIS C, Shete PB, Lienhardt C, Floyd K, et al
    Harnessing the Power of Data to Guide Local Action and End Tuberculosis.
    J Infect Dis. 2017;216.
    PubMed    
    
    
    
98. REID MJA, Goosby E
    Patient-Centered Tuberculosis Programs Are Necessary to End the Epidemic.
    J Infect Dis. 2017;216.
    PubMed    
    
    
    
99. CHIN DP, Hanson CL
    Finding the Missing Tuberculosis Patients.
    J Infect Dis. 2017;216.
    PubMed    
    
    
    
100. NAIDOO P, Theron G, Rangaka MX, Chihota VN, et al
     The South African Tuberculosis Care Cascade: Estimated Losses and Methodological Challenges.
     J Infect Dis. 2017;216.
     PubMed     Abstract available
     
     
     
101. CHURCHYARD G, Kim P, Shah NS, Rustomjee R, et al
     What We Know About Tuberculosis Transmission: An Overview.
     J Infect Dis. 2017;216.
     PubMed     Abstract available
     
     
     
102. TURNER RD, Chiu C, Churchyard GJ, Esmail H, et al
     Tuberculosis Infectiousness and Host Susceptibility.
     J Infect Dis. 2017;216.
     PubMed     Abstract available
     
     
     
103. MATHEMA B, Andrews JR, Cohen T, Borgdorff MW, et al
     Drivers of Tuberculosis Transmission.
     J Infect Dis. 2017;216.
     PubMed     Abstract available
     
     
     
104. AULD SC, Kasmar AG, Dowdy DW, Mathema B, et al
     Research Roadmap for Tuberculosis Transmission Science: Where Do We Go From Here and How Will We Know When We're There?
     J Infect Dis. 2017;216.
     PubMed     Abstract available
     
     
     
105. DOWDY DW, Grant AD, Dheda K, Nardell E, et al
     Designing and Evaluating Interventions to Halt the Transmission of Tuberculosis.
     J Infect Dis. 2017;216.
     PubMed     Abstract available
     
     
     
106. SHAH NS, Kim P, Kana BD, Rustomjee R, et al
     Getting to Zero New Tuberculosis Infections: Insights From the National Institutes of Health/US Centers for Disease Control and Prevention/Bill & Melinda Gates Foundation Workshop on Research Needs for Halting Tuberculosis Transmission.
     J Infect Dis. 2017;216.
     PubMed    
     
     
     
107. SALVATORE PP, Proano A, Kendall EA, Gilman RH, et al
     Linking individual natural history to population outcomes in tuberculosis.
     J Infect Dis. 2017 Nov 2. doi: 10.1093.
     PubMed     Abstract available
     
     
     October 2017
108. AGORO R, Benmerzoug S, Rose S, Bouyer M, et al
     An Iron-Rich Diet Decreases the Mycobacterial Burden and Correlates With Hepcidin Upregulation, Lower Levels of Proinflammatory Mediators, and Increased T-Cell Recruitment in a Model of Mycobacterium bovis Bacille Calmette-Guerin Infection.
     J Infect Dis. 2017;216:907-918.
     PubMed     Abstract available
     
     
     
109. BUNJUN R, Riou C, Soares AP, Thawer N, et al
     Effect of HIV on the frequency and number of Mycobacterium tuberculosis-specific CD4+ T cells in blood and the airways in latent tuberculosis infection.
     J Infect Dis. 2017 Oct 5. doi: 10.1093.
     PubMed     Abstract available
     
     
     September 2017
110. ROCKWOOD N, Sirgel F, Streicher E, Warren R, et al
     Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence.
     J Infect Dis. 2017;216:632-640.
     PubMed     Abstract available
     
     
     August 2017
111. SINGH V, Prakhar P, Rajmani RS, Mahadik K, et al
     Histone Methyltransferase SET8 Epigenetically Reprograms Host Immune Responses to Assist Mycobacterial Survival.
     J Infect Dis. 2017;216:477-488.
     PubMed     Abstract available
     
     
     June 2017
112. FOLKVARDSEN DB, Norman A, Andersen AB, Rasmussen EM, et al
     Genomic epidemiology of a major Mycobacterium tuberculosis outbreak: Retrospective cohort study in a low incidence setting using sparse time-series sampling.
     J Infect Dis. 2017 Jun 28. doi: 10.1093.
     PubMed     Abstract available
     
     
     
113. GUPTA S, Cheung L, Pokkali S, Winglee K, et al
     Suppressor Cell-Depleting Immunotherapy With Denileukin Diftitox is an Effective Host-Directed Therapy for Tuberculosis.
     J Infect Dis. 2017;215:1883-1887.
     PubMed     Abstract available
     
     
     May 2017
114. YAO Y, Lai R, Afkhami S, Haddadi S, et al
     A novel virus-vectored respiratory mucosal vaccine enhances anti-tuberculosis immunity in a humanized model system.
     J Infect Dis. 2017 May 20. doi: 10.1093.
     PubMed     Abstract available
     
     
     
115. ANTHONY RM
     Sputum microscopy and tuberculosis infectiousness.
     J Infect Dis. 2017 May 16. doi: 10.1093.
     PubMed    
     
     
     
116. DATTA S, Sherman JM, Tovar MA, Bravard MA, et al
     Sputum microscopy with fluorescein diacetate predicts tuberculosis infectiousness.
     J Infect Dis. 2017 May 16. doi: 10.1093.
     PubMed     Abstract available
     
     
     April 2017
117. THUONG NTT, Heemskerk D, Tram TTB, Thao LTP, et al
     Leukotriene A4 Hydrolase Genotype and HIV Infection Influence Intracerebral Inflammation and Survival From Tuberculous Meningitis.
     J Infect Dis. 2017 Apr 17. doi: 10.1093.
     PubMed     Abstract available
     
     
     March 2017
118. OEHLERS SH, Cronan MR, Beerman RW, Johnson MG, et al
     Infection-Induced Vascular Permeability Aids Mycobacterial Growth.
     J Infect Dis. 2017;215:813-817.
     PubMed     Abstract available
     
     
     February 2017
119. HALLIDAY A, Whitworth H, Hermagild Kottoor S, Niazi U, et al
     Stratification of latent tuberculosis infection by cellular immune profiling.
     J Infect Dis. 2017 Feb 28. doi: 10.1093.
     PubMed     Abstract available
     
     
     
120. SHEN H, Gu J, Xiao H, Liang S, et al
     Selective Destruction of Interleukin 23-Induced Expansion of a Major Antigen-Specific gammadelta T-Cell Subset in Patients With Tuberculosis.
     J Infect Dis. 2017;215:420-430.
     PubMed     Abstract available
     
     
     January 2017
121. CLARK S, Lanni F, Marinova D, Rayner E, et al
     Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
     J Infect Dis. 2017 Jan 25. doi: 10.1093.
     PubMed     Abstract available
     
     
     
122. JANSSEN S, Schutz C, Ward AM, Huson MA, et al
     Hemostatic Changes Associated With Increased Mortality Rates in Hospitalized Patients With HIV-Associated Tuberculosis: A Prospective Cohort Study.
     J Infect Dis. 2017;215:247-258.
     PubMed     Abstract available
     
     
     December 2016
123. MARAIS S, Lai RP, Wilkinson KA, Meintjes G, et al
     Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis.
     J Infect Dis. 2016.
     PubMed     Abstract available
     
     
     October 2016
124. JEYANATHAN M, Damjanovic D, Yao Y, Bramson J, et al
     Induction of an immune protective T cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in man.
     J Infect Dis. 2016.
     PubMed     Abstract available
     
     
     September 2016
125. MARTINEZ N, Ketheesan N, West K, Vallerskog T, et al
     Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages from Diabetic Mice.
     J Infect Dis. 2016.
     PubMed     Abstract available
     
     
     August 2016
126. SINGH DK, Dwivedi VP, Ranganathan A, Bishai WR, et al
     Blockade of the Kv1.3 K+ channel enhances BCG vaccine efficacy by expanding central memory T lymphocytes.
     J Infect Dis. 2016.
     PubMed     Abstract available
     
     
     July 2016
127. CANADAY DH, Toossi Z
     Granulomatous responses in HIV/TB co-infection.
     J Infect Dis. 2016.
     PubMed    
     
     

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: